Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0HCD
|
||||
Drug Name |
2-(4-(methyl(3-(7-propyl-3-(trifluoromethyl)benzo[d]isoxazol-6-yloxy)propyl)amino)-2-(trifluoromethyl)phenyl)acetic acid
|
||||
Synonyms |
CHEMBL382789
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C24H24F6N2O4
|
||||
Canonical SMILES |
CCCc1c(OCCCN(C)c2ccc(CC(=O)O)c(c2)C(F)(F)F)ccc3c(noc13)C(F)(F)F
|
||||
InChI |
InChI=1S/C24H24F6N2O4/c1-3-5-16-19(9-8-17-21(16)36-31-22(17)24(28,29)30)35-11-4-10-32(2)15-7-6-14(12-20(33)34)18(13-15)23(25,26)27/h6-9,13H,3-5,10-12H2,1-2H3,(H,33,34)
|
||||
InChIKey |
XNZXFVFJRAJUDY-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Peroxisomeproliferator activated receptor delta | Target Info | [1587926] | ||
Oxysterols receptor LXR-alpha | Target Info | [1587926] | |||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Wnt signaling pathway | ||||
WikiPathways | Wnt Signaling Pathway and Pluripotency | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
NRF2 pathway | |||||
Nuclear Receptors Meta-Pathway | |||||
Vitamin D Receptor Pathway | |||||
Ectoderm Differentiation | |||||
Adipogenesis | |||||
Nuclear ReceptorsWP299:Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
PPAR Alpha Pathway | |||||
Liver X Receptor Pathway | |||||
SREBF and miR33 in cholesterol and lipid homeostasis | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.